Education
About Us
Working with TipRanks
Follow Us
Angiodynamics, Inc. (ANGO)
:ANGO
ANGO Stock Chart & Stats
$11.82
$2.78(29.57%)
At close: 4:00 PM EST
$11.82
$2.78(29.57%)
Day’s Range― - ―
52-Week Range$8.27 - $13.99
Previous CloseN/A
Volume2.49M
Average Volume (3M)468.51K
Market Cap
$492.34M
Enterprise Value$393.28M
Total Cash (Recent Filing)$38.76M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Jan 01, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding41,199,844
10 Day Avg. Volume515,518
30 Day Avg. Volume468,506
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)2.28
Price to Sales (P/S)1.43
P/FCF Ratio-28.65
Enterprise Value/Market Cap0.80
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit2.42
Enterprise Value/Ebitda-341.98
Forecast
1Y Price Target
$19.33Price Target Upside63.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTop- and bottom-line beat in fiscal 1Q26; FY26 guidance raised.
Market AdoptionClinical trial results may boost market adoption.
Reimbursement EnhancementsANGO has the opportunity to capitalize on the recent prostate momentum and reduce the hurdles for patient access related to reimbursement.
Bears Say
AngioDynamics News
ANGO FAQ
What was Angiodynamics, Inc.’s price range in the past 12 months?
Angiodynamics, Inc. lowest stock price was $8.27 and its highest was $13.99 in the past 12 months.
What is Angiodynamics, Inc.’s market cap?
Angiodynamics, Inc.’s market cap is $492.34M.
When is Angiodynamics, Inc.’s upcoming earnings report date?
Angiodynamics, Inc.’s upcoming earnings report date is Jan 01, 2026 which is in 20 days.
How were Angiodynamics, Inc.’s earnings last quarter?
Angiodynamics, Inc. released its earnings results on Oct 02, 2025. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.122 by $0.022.
Is Angiodynamics, Inc. overvalued?
According to Wall Street analysts Angiodynamics, Inc.’s price is currently Undervalued.
Does Angiodynamics, Inc. pay dividends?
Angiodynamics, Inc. does not currently pay dividends.
What is Angiodynamics, Inc.’s EPS estimate?
Angiodynamics, Inc.’s EPS estimate is -0.1.
How many shares outstanding does Angiodynamics, Inc. have?
Angiodynamics, Inc. has 41,199,844 shares outstanding.
What happened to Angiodynamics, Inc.’s price movement after its last earnings report?
Angiodynamics, Inc. reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.122. Following the earnings report the stock price went up 6.052%.
Which hedge fund is a major shareholder of Angiodynamics, Inc.?
Currently, no hedge funds are holding shares in ANGO
AngioDynamics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.33 (63.54% Upside)
$19.33 (63.54% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 133.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $121.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 7.7%
Last 30 Days ▼ 7.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.94%
12-Months-Change
Fundamentals
Return on Equity
-17.10%
Trailing 12-Months
Asset Growth
-9.53%
Trailing 12-Months
Company Description
Angiodynamics, Inc.
AngioDynamics, Inc. is a medical device company that specializes in innovative products for the minimally invasive treatment of various medical conditions. The company operates primarily in the vascular access, peripheral vascular, and oncology markets, offering a range of products including vascular access devices, ablation systems, and drainage systems. AngioDynamics is dedicated to improving patient outcomes through its advanced technologies and solutions designed for use in hospitals and outpatient settings.
ANGO Company Deck
ANGO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth across various segments, particularly in the Med Tech and Mechanical Thrombectomy areas, and a positive outlook with increased guidance. However, tariff expenses and a continued adjusted net loss were concerns.View all ANGO earnings summariesANGO Stock 12 Month Forecast
Average Price Target
$19.33
▲(63.54% Upside)
Technical Analysis
InfuSystem Holdings
―
Orasure Technologies
―
Stereotaxis
―
Utah Medical Products
―
Sanara MedTech
―
Ownership Overview
5.37% Insiders
16.24% Mutual Funds
37.65% Other Institutional Investors
29.49% Public Companies and
Individual Investors